Indivior (OTCMKTS:INVVY) Stock Crosses Below Fifty Day Moving Average – Here’s Why

Posted by Defense World Staff on Feb 11th, 2026

Indivior PLC (OTCMKTS:INVVY – Get Free Report)’s stock price crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $21.85 and traded as low as $21.64. Indivior shares last traded at $21.8455, with a volume of 8,100 shares changing hands.

Analysts Set New Price Targets

Separately, Craig Hallum reissued a “buy” rating and issued a $50.00 target price on shares of Indivior in a report on Friday, January 9th. One analyst has rated the stock with a Buy rating, According to data from MarketBeat, Indivior currently has a consensus rating of “Buy” and an average price target of $50.00.

Check Out Our Latest Research Report on INVVY

Indivior Stock Down 1.8%

The firm has a market capitalization of $3.01 billion, a price-to-earnings ratio of 20.81 and a beta of 0.35. The company has a 50-day moving average price of $21.85 and a 200-day moving average price of $21.85.

Indivior Company Profile

(Get Free Report)

Indivior PLC is a specialty pharmaceutical company focused on developing and commercializing treatments for addiction and related disorders. The company’s core business centers on addressing opioid use disorder through a portfolio of branded pharmaceuticals and delivery systems designed to support long-term recovery. Indivior’s therapies are aimed at improving patient outcomes by reducing withdrawal symptoms and lowering the risk of relapse.

The company’s flagship product, Suboxone®, is a buprenorphine-naloxone sublingual film approved for the treatment of opioid dependence.